When applying MLN0128 in vivo, mTORC1/2 inhibition led to disease stabilization in an early stage and partial tumor regression in a late stage of AKT/YAP127A induced iCCA in mice. The gene discussed is AKT1; the disease is infantile convulsions and choreoathetosis.